Stock Alert: Epizyme (EPZM)

2020-02-14

Epizyme Inc.’s (EPZM) first drug TAZVERIK, which was granted accelerated FDA approval for the treatment of metastatic or locally advanced epithelioid sarcoma last month, will […]